Kinaxis Announces Normal Course Issuer Bid

Executive Summary

• Kinaxis Inc. announced that the Toronto Stock Exchange has accepted its notice to commence a new Normal Course Issuer Bid (NCIB) allowing the company to repurchase up to 1,403,042 shares (≈5% of outstanding shares).
• An Automatic Share Purchase Plan (ASPP) with RBC Dominion Securities has been established to enable purchases during blackout periods and other regulatory restrictions.
• The board believes the NCIB will enhance shareholder value by buying undervalued shares and cancelling them, increasing equity for remaining shareholders.

Key Details

• NCIB Scope: Up to 1,403,042 common shares may be purchased between Nov 12 2025 and Nov 11 2026 (or earlier if completed/terminated).
• Share Count Basis: 28,060,844 shares issued and outstanding as of Oct 31 2025; the NCIB represents ~5% of this total.
• Daily Purchase Limit: Maximum of 14,137 shares per day (25% of average daily volume of 56,549 shares over the prior six months).
• Purchase Mechanics: Acquisitions will be made on TSX or alternative Canadian trading systems at prevailing market prices, subject to regulatory approvals. All repurchased shares will be cancelled.
• ASPP Arrangement: Kinaxis entered into an ASPP with RBC Dominion Securities Inc. to facilitate purchases when the company is otherwise prohibited from buying (e.g., blackout periods). Purchases under the ASPP are at RBC DS’s discretion within parameters set by Kinaxis.
• Previous NCIB Reference: The prior NCIB (expired Nov 5 2025) allowed purchase of up to 1,404,639 shares; Kinaxis repurchased and cancelled 706,736 shares at a weighted‑average price of ~$181.96 per share (including commissions).
• Board Rationale: Management believes market price may not fully reflect intrinsic value; repurchasing shares is viewed as a desirable use of corporate funds and beneficial to existing shareholders.

Notable Quotes

(No direct quotes were provided in the release.)